TreeFrog Therapeutics raised €64M in a Series B round in Sep 2021. The company is based in Bordeaux, France. Investors in the round: Bpifrance Large Venture, Bristol Myers Squibb, Leonard Green & Partners and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
